Candida albicans and Candida Tropicalis Antigen Immunotherapy in Recalcitrant Warts: Mechanisms, Efficacy, and Safety

Authors

  • Amin Mohamed Amin Amer , Ayman Mohamed Marei , Fatma Elzahraa Kamal Eldin Abdelfattah Elshamy , Hala Mohamed Morsi Author

DOI:

https://doi.org/10.48047/6emfrw24

Keywords:

Candida albicans, Candida Tropicalis, Immunotherapy, Recalcitrant Warts

Abstract

Background: Recalcitrant warts remain a therapeutic challenge in dermatology, venereology and andrology, particularly in patients with multiple, longstanding, or anogenital lesions that fail destructive modalities. Intralesional immunotherapy has emerged as a host-directed strategy that enhances cell-mediated immunity against human papillomavirus (HPV). Among available antigens, Candida albicansextracts  are the most widely studied and are increasingly

Downloads

Download data is not yet available.

References

Sterling JC, Gibbs S, Haque Hussain SS, Mohd Mustapa MF, Handfield-Jones SE. British Association of Dermatologists’ guidelines for the management of cutaneous warts 2014. Br J Dermatol. 2014;171(4):696–712.

Kwok CS, Holland R, Gibbs S. Efficacy of topical treatments for cutaneous warts: systematic review and meta-analysis. Cochrane Database Syst Rev. 2012;(9):CD001781.

Downloads

Published

2024-11-20

How to Cite

Candida albicans and Candida Tropicalis Antigen Immunotherapy in Recalcitrant Warts: Mechanisms, Efficacy, and Safety (Amin Mohamed Amin Amer , Ayman Mohamed Marei , Fatma Elzahraa Kamal Eldin Abdelfattah Elshamy , Hala Mohamed Morsi , Trans.). (2024). Cuestiones De Fisioterapia, 53(03), 6782-6792. https://doi.org/10.48047/6emfrw24